Aligos Therapeutics (ALGS) EBITDA Margin (QoQ) (2021 - 2026)
Aligos Therapeutics (ALGS) EBITDA Margin (QoQ) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.05 Bn | 131.20 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.99 Bn | 78.00 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.49 Bn | 60.31 Bn | 1.37 Bn |
| 4 | Moderna | 56.79 Bn | 51.65 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.14 Bn | 37.05 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.27 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.71 Bn | 9.32 Bn | 668.28 Mn |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.35 Bn | 26.51 Bn | - |
| 10 | Aligos Therapeutics | 70.20 Mn | 39.76 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.20 Mn |
| Jun 30, 2025 | 426,342.00 |
| Mar 31, 2025 | -695,732.00 |
| Dec 31, 2024 | 238,034.00 |
| Sep 30, 2024 | 87,906.00 |
| Jun 30, 2024 | 68,712.00 |
| Mar 31, 2024 | -546,110.00 |
| Dec 31, 2023 | 404,214.00 |
| Sep 30, 2023 | -131,193.00 |
| Jun 30, 2023 | 1.66 Mn |
| Mar 31, 2023 | -1.69 Mn |
| Dec 31, 2022 | 29,837.00 |
| Mar 31, 2022 | 895,705.00 |
| Dec 31, 2021 | -818,859.00 |
| Sep 30, 2021 | -23,787.00 |
| Jun 30, 2021 | 113,476.00 |